Juan Cueva

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García et al. · The Lancet · 2023 · 175 citations

Oncology, Cervical Cancer, Metronomic Therapy +6

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

Lorena Alonso‐Alconada, Laura Muinelo‐Romay, Kadri Madissoo et al. · Molecular Cancer · 2014 · 100 citations · Full text

M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis

A. De la Fuente, Lorena Alonso‐Alconada, Clotilde Costa et al. · JNCI Journal of the National Cancer Institute · 2015 · 92 citations · Full text

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano et al. · The Lancet Oncology · 2024 · 89 citations

Gynecological Surgery, Medicine, Metronomic Therapy +6

Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes

Clotilde Costa, Laura Muinelo‐Romay, Víctor Cebey-López et al. · Cancers · 2020 · 70 citations · Full text